- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Sep 29, 2023
Highlights
- Total Revenue (TTM)
- $6.49M
- Gross Profit (TTM)
- $6.49M
- EBITDA (TTM)
- -$63.57M
- Year Range
- $0.88 - $17.25
- Target Price
- $16.00
- ROA (TTM)
- -157.02%
- ROE (TTM)
- 649.66%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ANL Performance Chart
Adlai Nortye Ltd. American Depositary Shares (ANL) is up 693.0% since the beginning of the year. At $11 per share, ANL is trading 34.7% below its 52-week high of $17.
Loading charts...
Returns By Period
Adlai Nortye Ltd. American Depositary Shares (ANL) has returned 692.96% so far this year and 586.54% over the past 12 months.
Adlai Nortye Ltd. American Depositary Shares
- 1D
- -2.76%
- 1M
- -24.78%
- YTD
- 692.96%
- 6M
- 727.94%
- 1Y
- 586.54%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
ANL Monthly Returns History
Based on dividend-adjusted daily data since Sep 29, 2023, ANL's average daily return is +0.21%, while the average monthly return is +17.04%. At this rate, an investment would double in approximately 0.4 years.
Historically, 42% of months were positive and 58% were negative. The best month was Jan 2026 with a return of +648.6%, while the worst month was Jun 2024 at -55.1%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ANL closed higher 46% of trading days. The best single day was Jan 29, 2026 with a return of +88.2%, while the worst single day was Nov 11, 2024 at -19.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 648.59% | -26.06% | -11.96% | 106.21% | -16.33% | -5.70% | 692.96% | ||||||
| 2025 | -21.05% | 6.60% | -11.06% | -8.46% | -1.09% | -19.23% | -2.72% | 18.18% | 6.43% | -20.50% | 11.19% | -10.69% | -47.12% |
| 2024 | 1.56% | -21.69% | 24.18% | 55.43% | -47.39% | -55.10% | 7.36% | -19.05% | -29.94% | 0.76% | 11.50% | 20.41% | -70.13% |
| 2023 | -46.33% | 36.65% | -18.27% | -40.07% |
Benchmark Metrics
Adlai Nortye Ltd. American Depositary Shares has an annualized alpha of 41.49%, beta of 0.80, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since October 02, 2023.
- This stock participated in 233.22% of S&P 500 Index downside but only 49.13% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 41.49%
- Beta
- 0.80
- R²
- 0.01
- Upside Capture
- 49.13%
- Downside Capture
- 233.22%
Return for Risk
Risk / Return Rank
ANL ranks 97 for risk / return — in the top 97% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Adlai Nortye Ltd. American Depositary Shares (ANL) and compare them to S&P 500 Index.
| ANL | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.99 | 2.24 | +1.75 |
Sortino ratioReturn per unit of downside risk | 4.72 | 3.07 | +1.65 |
Omega ratioGain probability vs. loss probability | 1.59 | 1.41 | +0.18 |
Calmar ratioReturn relative to maximum drawdown | 11.58 | 2.93 | +8.65 |
Martin ratioReturn relative to average drawdown | 35.33 | 13.52 | +21.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Adlai Nortye Ltd. American Depositary Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Adlai Nortye Ltd. American Depositary Shares was 94.13%, occurring on Dec 8, 2025. Recovery took 86 trading sessions.
The current Adlai Nortye Ltd. American Depositary Shares drawdown is 32.17%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -94.13%Dec 2025 | 2y 2mo | 4mo 7d | 2y 6moOct 2023 - Apr 2026 |
2026 bear market2026 | -35.54%May 2026 | 28d | — | 1mo 14dApr 2026 - now |
2026 correction2026 | -15.50%Apr 2026 | 0s | 2d | 2dApr 2026 - Apr 2026 |
Drawdown Indicators
| ANL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.13% | -56.78% | -37.35% |
Max Drawdown (1Y)Largest decline over 1 year | -51.11% | -9.10% | -42.01% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -32.17% | -0.74% | -31.43% |
Average DrawdownAverage peak-to-trough decline | -65.79% | -10.72% | -55.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.72% | 1.97% | +14.75% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Adlai Nortye Ltd. American Depositary Shares over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Adlai Nortye Ltd. American Depositary Shares is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ANL
Add Adlai Nortye Ltd. American Depositary Shares to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ANL